Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Ainos, Inc.

Get SEC filing alerts via email and in your feed for Ainos, Inc.

AIMD AIMDW

Ainos, Inc.

About Ainos, Inc.

Ainos, Inc. is a diversified healthcare company specializing in novel point-of-care testing (POCT), low-dose interferon alpha therapeutics (VELDONA), and synthetic RNA-based preventative medicine. Its product portfolio includes VELDONA Pet supplements and AI-powered VOC sensing POCT devices for rapid, non-invasive health diagnostics. Operating primarily in Taiwan, Ainos leverages outsourced manufacturing and global distribution partnerships to develop affordable, telehealth-friendly healthcare solutions targeting human and animal health markets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Ainos, Inc.

1
1
Ainos, Inc. Ainos, Inc. Reports Significant Revenue Decline and Net Loss in Q1 2026

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
Ainos, Inc. Ainos, Inc. Reports 499% Revenue Growth to $124,157 in 2025 Fiscal Year

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Ainos, Inc. Ainos, Inc. Reports Revenue Growth and Ongoing Losses in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Ainos, Inc. Ainos, Inc. Reports Revenue Growth and Increased Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Ainos, Inc. Ainos, Inc. Reports 412% Revenue Growth to $106,207 in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Ainos, Inc. Ainos, Inc. Reports 83% Revenue Decline, Shifts Focus to VELDONA Product Line

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Ainos, Inc. Ainos, Inc. Reports Significant Financial Decline, Net Losses, and Increased Liabilities in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments